The authors of A different paper described the administration of HBOT as adjuvant therapy for acute macular neuroretinopathy in systemic lupus erythematosus in conjunction with immunosuppression in two patients [eleven].Built-in information logging modules report controlled and calculated information and facts and produce useable results facts. As